Spero Therapeutics SPRO
NASDAQ SPRO
$1.11 -0.02 (-1.77%)
At close: Oct 23, 2026 · 4:00 PM EDT

Spero Therapeutics (SPRO) Interest & Investment Income (2019 - 2026)

Updated

Spero Therapeutics (SPRO) recorded Interest & Investment Income of $377,000 in Q2 2026, down 49.1% from $740,000 a year earlier but up 12.2% from the prior quarter.

Analysis

Spero Therapeutics (SPRO) Interest & Investment Income (2019 - 2026) Analysis & Trends

On a TTM basis, Spero Therapeutics' Interest & Investment Income came in at $1.62 million as of Jun 30, 2026, down 57.5% year-over-year; for FY2025, it was $2.51 million, down 46.9% from FY2024.

  • Annual Interest & Investment Income has a five-year compound annual growth rate of 44.3% (FY2020 to FY2025).
  • Across earlier years, Interest & Investment Income came in at $4.74 million in FY2024 (+20.3%), $3.94 million in FY2023 (+256.0%), $1.11 million in FY2022 (+219.7%) and $346,000 in FY2021 (-13.7%).
  • Quarterly Interest & Investment Income has ranged from $72,000 in Q1 2022 to $1.33 million in Q1 2024 over the past five years.
  • On a year-over-year basis, Interest & Investment Income has declined for seven consecutive quarters, with an average decline of 34.8% over the last eight quarters.
  • Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 840.8% in Q4 2022, against a decline of 63.4% in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $336,000 (Q1 2026), $376,000 (Q4 2025) and $532,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 186.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 80.00 Mn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn -
10 Spero Therapeutics 64.54 Mn -131.24 Mn - 377,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 377,000.00
Mar 31, 2026 336,000.00
Dec 31, 2025 376,000.00
Sep 30, 2025 532,000.00
Jun 30, 2025 740,000.00
Mar 31, 2025 864,000.00
Dec 31, 2024 1.03 Mn
Sep 30, 2024 1.18 Mn
Jun 30, 2024 1.20 Mn
Mar 31, 2024 1.33 Mn
Dec 31, 2023 1.04 Mn
Sep 30, 2023 950,000.00
Jun 30, 2023 982,000.00
Mar 31, 2023 963,000.00
Dec 31, 2022 715,000.00
Sep 30, 2022 208,000.00
Jun 30, 2022 111,000.00
Mar 31, 2022 72,000.00
Dec 31, 2021 76,000.00
Sep 30, 2021 90,000.00
API Access

Spero Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=SPRO&period=max&api_key=YOUR_API_KEY